Kanso Diagnostics vs MeMed
Kanso Diagnostics vs MeMed, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kanso Diagnostics is on 53/100 and MeMed on 61/100.
Where each one leads
Kanso Diagnostics
- headcount growth: +22.1% against -8.4%
MeMed
- our overall score: 61/100 against 53/100
- agent readiness: 35/100 against 28/100
- domain rating: 46/100 against 1/100
- headcount: 99 against 7
- funding raised: $196M against $1.8M
- LinkedIn following: 21,207 against 778
At a glance
| Measure | Kanso Diagnostics | MeMed |
|---|---|---|
| What it is | Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need. | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. |
| Category | Healthcare, Diagnostics, Genetics, Pathology | Healthcare, Blood, Diagnostics, MedTech |
| Sells toBusiness model | B2B | B2B, B2G |
| Offering | Platform | Software, Hardware |
| Founded | 2021 | 2009 |
| Headquarters | Or Yehuda, Israel | Tirat Carmel, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Kanso Diagnostics | MeMed |
|---|---|---|
| Employees | 7 | 99 |
| Headcount growthLast 12 months | +22.1% | -8.4% |
| Total funding | $1.8M | $196M |
| Latest round | Seed | Series E |
| LinkedIn followers | 778 | 21,207 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Kanso Diagnostics | MeMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 61/100 |
| Traction | 40/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 39/100 | 29/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (28/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 1/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Kanso Diagnostics | MeMed |
|---|---|---|
| Hosting | Netlify | Self Managed |
| CDN | Netlify | Not detected |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
Kanso Diagnostics vs MeMed: common questions
Which is better, Kanso Diagnostics or MeMed?
On our 0-100 score MeMed rates higher (61/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Kanso Diagnostics and MeMed compare on the numbers?
Kanso Diagnostics leads on headcount growth (+22.1% against -8.4%). MeMed leads on our overall score (61/100 against 53/100), agent readiness (35/100 against 28/100), domain rating (46/100 against 1/100), headcount (99 against 7), funding raised ($196M against $1.8M), LinkedIn following (21,207 against 778).
Read the full Kanso Diagnostics review and pricing or the MeMed review and pricing. You can also browse other Kanso Diagnostics alternatives we track.